Page last updated: 2024-08-16

propidium and n-arachidonoyl l-serine

propidium has been researched along with n-arachidonoyl l-serine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexandrovich, A; Cohen-Yeshurun, A; Leker, RR; Mechoulam, R; Shohami, E; Trembovler, V; Willner, D	1

Other Studies

1 other study(ies) available for propidium and n-arachidonoyl l-serine

Article	Year
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:8 Topics: Animals; Arachidonic Acids; Astrocytes; Behavior, Animal; Blotting, Western; Brain; Brain Injuries; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coloring Agents; Male; Mice; Neural Stem Cells; Neurogenesis; Propidium; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Serine; Treatment Outcome; TRPV Cation Channels	2013

Article

Year

N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:8

Topics: Animals; Arachidonic Acids; Astrocytes; Behavior, Animal; Blotting, Western; Brain; Brain Injuries; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coloring Agents; Male; Mice; Neural Stem Cells; Neurogenesis; Propidium; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Serine; Treatment Outcome; TRPV Cation Channels

2013